Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07852962
PHASE1
Study to Assess Drug Levels, Immune Response, Safety and Tolerability of BMS-986446 in Healthy Chinese Participants.
Sponsor: Bristol-Myers Squibb
View on ClinicalTrials.gov
Summary
The purpose of this study is to assess the drug levels, immune response, safety and tolerability of BMS-986446 in healthy Chinese participants.
Official title: A Phase 1, Double-blind, Randomized, Placebo-controlled, Single-dose Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Tolerability of BMS-986446 Following Intravenous Administration in Healthy Chinese Participants
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2027-02-10
Completion Date
2027-07-18
Last Updated
2026-10-01
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
BMS-986446
Specified dose on specified days
OTHER
Placebo
Specified dose on specified days